Market Place
Sourcing Support
EDQM has validated updated CEP of Vinorelbine of Minakem, sole Mfg in EU
25 Jun 2024 //
PRESS RELEASE
Merus Presents Updated Analysis of Zenocutuzumab, Trastuzumab, and Vinorelbine
10 Dec 2021 //
GLOBENEWSWIRE
In-depth study on Industry Size and Analysis on Emerging Growth Factors
20 Mar 2020 //
OPENPR
TLC announces completion of $27 M financing
28 Oct 2019 //
BIOSPECTRUMASIA
Ingenus Pharms`s Generic Vinorelbine Tartrate Receives Approval in US
09 Aug 2019 //
FDA
JIANGSU YEW Pharmaceutical Co. Ltd. Fails EDQM Inspection
15 Sep 2018 //
EDQM
Five drugs suspended after factory inspection
25 Oct 2017 //
FDA
Treating Metastatic Breast Cancer with Olaparib
30 Sep 2017 //
MEDICAL NEWS
Anetumab Ravtansine Is Unable to Outperform Vinorelbine
26 Jul 2017 //
MESOTHELIOMA NEWS
AstraZeneca Phase III breast cancer trial met primary endpoint
23 Feb 2017 //
EUROPEAN PHARMACEUTICAL
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.